Extract from the Register of European Patents

EP About this file: EP0723774

EP0723774 - Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  20.07.2007
Database last updated on 14.03.2026
Most recent event   Tooltip06.11.2009Change - representativepublished on 09.12.2009  [2009/50]
Applicant(s)For all designated states
L'Oréal
14, rue Royale
75008 Paris / FR
[N/P]
Former [2000/49]For all designated states
L'OREAL
14, rue Royale
75008 Paris / FR
Former [1996/31]For all designated states
L'OREAL
14, rue Royale
F-75008 Paris / FR
Inventor(s)01 / Breton, Lionel
14, rue de Satory
F-78000 Versailles / FR
02 / de Lacharriere, Olivier
6, rue Edmond Roger
F-75015 Paris / FR
[1996/31]
Representative(s)Bernstein, Claire Jacqueline
L'Oréal
Service DIPI
9 Rue Pierre Dreyfus
92110 Clichy / FR
[N/P]
Former [2009/50]Bernstein, Claire Jacqueline
L'Oréal D.I.P.I 25-29, Quai Aulagnier
92665 Asnières-sur-Seine Cédex / FR
Former [2005/41]Bernstein, Claire Jacqueline
L'OREAL D.I.P.I 25-29, Quai Aulagnier
92600 Asnieres-sur-Seine / FR
Former [1996/31]Lhoste, Catherine
L'OREAL, D.P.I., 90 rue du Général Roguet
F-92583 Clichy Cédex / FR
Application number, filing date96400007.902.01.1996
[1996/31]
Priority number, dateFR1995000090026.01.1995         Original published format: FR 9500900
[1996/31]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0723774
Date:31.07.1996
Language:FR
[1996/31]
Type: B1 Patent specification 
No.:EP0723774
Date:06.12.2000
Language:FR
[2000/49]
Search report(s)(Supplementary) European search report - dispatched on:EP07.06.1996
ClassificationIPC:A61K7/48, A61K38/22
[1996/31]
CPC:
A61Q19/005 (EP,US); A61K8/64 (EP,US); A61K31/167 (EP,US);
A61K38/225 (EP,US); A61P17/00 (EP); A61P29/00 (EP);
A61P31/04 (EP); A61P43/00 (EP); A61Q19/008 (EP,US);
C07K16/26 (EP,US); A61K2800/70 (EP,US); A61Q1/14 (EP,US);
A61Q19/002 (EP,US); A61Q19/004 (EP,US); A61Q19/08 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/31]
TitleGerman:Kosmetische, dermatologische oder pharmazeutische Zusammensetzung, enthaltend einen Antagonisten der CGRP[1996/31]
English:Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP[1996/31]
French:Utilisation d'un antagoniste de CGRP dans une composition cosmétique, pharmaceutique ou dermatologique et composition obtenue[1996/31]
Examination procedure24.06.1996Examination requested  [1996/35]
24.06.1996Request for accelerated examination filed
13.09.1996Despatch of a communication from the examining division (Time limit: M06)
13.09.1996Decision about request for accelerated examination - accepted: Yes
11.03.1997Reply to a communication from the examining division
07.08.1997Despatch of a communication from the examining division (Time limit: M04)
10.12.1997Reply to a communication from the examining division
23.02.1998Despatch of a communication from the examining division (Time limit: M04)
23.06.1998Reply to a communication from the examining division
07.01.1999Despatch of a communication from the examining division (Time limit: M04)
12.05.1999Reply to a communication from the examining division
04.07.2000Despatch of communication of intention to grant (Approval: No)
05.09.2000Fee for grant paid
05.09.2000Fee for publishing/printing paid
08.09.2000Despatch of communication of intention to grant (Approval: later approval)
15.09.2000Communication of intention to grant the patent
Opposition(s)Opponent(s)01  01.09.2001    ADMISSIBLE
Boehringer Ingelheim GmbH
D-55216 Ingelheim / DE
 [2001/43]
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
15.10.2001Invitation to proprietor to file observations on the notice of opposition
18.06.2002Reply of patent proprietor to notice(s) of opposition
11.12.2003Date of oral proceedings
05.02.2004Despatch of minutes of oral proceedings
05.02.2004Date of despatch of rejection of opposition
23.05.2007Legal effect of revocation of patent [2007/34]
19.07.2007Despatch of communication that the patent will be revoked
Appeal following opposition01.04.2004Appeal received No.  T0448/04
14.06.2004Statement of grounds filed
19.07.2007Interlocutory revision of appeal
19.07.2007Result of appeal procedure: revocation of the patent
23.05.2007Date of oral proceedings
01.06.2007Minutes of the oral proceedings despatched
Fees paidRenewal fee
02.02.1998Renewal fee patent year 03
11.01.1999Renewal fee patent year 04
10.01.2000Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.12.2000
GR06.12.2000
IE02.01.2001
LU02.01.2001
BE31.01.2001
CH31.01.2001
LI31.01.2001
MC06.02.2001
PT06.03.2001
[2006/39]
Former [2004/39]AT06.12.2000
GR06.12.2000
IE02.01.2001
LU02.01.2001
BE31.01.2001
CH31.01.2001
LI31.01.2001
PT06.03.2001
Former [2004/07]AT06.12.2000
GR06.12.2000
IE02.01.2001
BE31.01.2001
CH31.01.2001
LI31.01.2001
PT06.03.2001
Former [2002/15]AT06.12.2000
IE02.01.2001
BE31.01.2001
CH31.01.2001
LI31.01.2001
PT06.03.2001
Former [2002/14]AT06.12.2000
IE02.01.2001
BE31.01.2001
PT06.03.2001
Former [2002/12]AT06.12.2000
BE31.01.2001
PT06.03.2001
Former [2002/11]AT06.12.2000
PT06.03.2001
Former [2001/37]AT06.12.2000
Documents cited:Search[X]   T. L. BUCKLEY ET AL: "The Partial Inhibition of Inflammatory Responses Induced By Capsaicin using the Fab Fragment of a Selective Calcitonin Gene-Related Peptide Antiserum in Rabbit Skin", NEUROSCIENCE, vol. 48, no. 4, 1992, GB, pages 963 - 968, XP002002770 [X] 1,2,8 * abstract *

DOI:   http://dx.doi.org/10.1016/0306-4522(92)90284-9
 [X]   K. J. ESCOTT ET AL: "Effect of a calcitonin gene-related peptide antagonist (CGRP 8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve", BRITISH JOURNAL OF PHARMACOLOGY, vol. 110, no. 2, October 1993 (1993-10-01), GB, pages 772 - 776, XP002002771 [X] 1,2,8 * abstract *
 [X]   S. R. HUGHES ET AL: "A calcitonin gene-related peptide (CGRP) antagonist (CGRP 8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin", BRITISH JOURNAL OF PHARMACOLOGY, vol. 104, no. 3, November 1991 (1991-11-01), GB, pages 738 - 742, XP002002772 [X] 1,2,8 * abstract * * page 741, column L, paragraph L - column R, paragraph L *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.